Jazz Pharmaceuticals plc (JAZZ)

Jazz Pharmaceuticals Market Cap

Jazz Pharmaceuticals has a market cap or net worth of $14.38 billion as of June 9, 2026. Its market cap has increased by 116.41% in one year.

• Market Cap: 14.38B
• Enterprise Value: 16.92B
• 1-Year Change: 116.41%
• Ranking: #738
• Category: Large-Cap
• Stock Price: $229.19

Market Cap Chart

Since June 1, 2007, Jazz Pharmaceuticals's market cap has increased from $435.30M to $14.38B, an increase of 3,203.48%. That is a compound annual growth rate of 20.17%.

Market Cap History

Date	Market Cap	% Change
Jun 8, 2026	14.56B	40.94%
Dec 31, 2025	10.33B	38.75%
Dec 31, 2024	7.45B	-3.86%
Dec 29, 2023	7.74B	-22.80%
Dec 30, 2022	10.03B	28.09%
Dec 31, 2021	7.83B	-14.84%
Dec 31, 2020	9.20B	8.89%
Dec 31, 2019	8.45B	12.94%
Dec 31, 2018	7.48B	-7.37%
Dec 29, 2017	8.07B	23.62%
Dec 30, 2016	6.53B	-24.46%
Dec 31, 2015	8.64B	-12.72%
Dec 31, 2014	9.90B	35.42%
Dec 31, 2013	7.31B	137.27%
Dec 31, 2012	3.08B	89.28%
Dec 30, 2011	1.63B	112.63%
Dec 31, 2010	765.90M	213.64%
Dec 31, 2009	244.20M	340.00%
Dec 31, 2008	55.50M	-84.62%
Dec 31, 2007	360.90M	-17.09%
Jun 1, 2007	435.30M	-

View and export this data all the way back to 2007. Sign Up Today.

Data Source: Nasdaq Data Link Last updated: Jun 8, 2026

Market cap data is provided by Nasdaq Data Link. The current market cap updates continuously throughout the trading day, while the historical market cap is updated daily after market close.

Update frequency:

Daily

Last checked:

Jun 9, 2026

Data Sources Report a data error

Related Stocks

Company	Market Cap
Insmed	20.42B
Moderna	18.82B
Genmab	15.12B
Exelixis	13.25B
BridgeBio Pharma	13.24B
Ascendis Pharma	13.07B
Ionis Pharmaceuticals	12.31B
Axsome Therapeutics	11.96B